Old Web
English
Sign In
Acemap
>
authorDetail
>
Xianzhong Guo
Xianzhong Guo
Fujian Medical University
Internal medicine
Medicine
Oncology
Cost-effectiveness analysis
first line
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis.
2021
International Journal of Clinical Pharmacy
Shaohong Luo
Xiuhua Weng
Shen Lin
Xiaoting Huang
Lingning Huang
Wei Zhou
Xianzhong Guo
Xiongwei Xu
Show All
Source
Cite
Save
Citations (0)
A signal-off fluorescent strategy for deferasirox effective detection using carbon dots as probe and Cu2+ as medium.
2021
Analytica Chimica Acta
Wendi Han
Chenfang Miao
Xintian Zhang
Yinning Lin
Xiaoli Hao
Zhengjun Huang
Shaohuang Weng
Xinhua Lin
Xianzhong Guo
Jianyong Huang
Show All
Source
Cite
Save
Citations (2)
First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
2020
American Journal of Clinical Oncology
Xiuhua Weng
Xiaoting Huang
Hongchao Li
Shen Lin
Xin Rao
Xianzhong Guo
Pinfang Huang
Show All
Source
Cite
Save
Citations (9)
1